Mitsubishi Tanabe Pharma Corporation, a leading Japanese pharmaceutical company, has implemented the UiPath Business Automation Platform to improve operational efficiency and productivity. The company aims to create hope for those facing illnesses and is facing challenges in developing valuable drugs that genuinely meet the needs of patients. The introduction of UiPath has allowed Mitsubishi Tanabe Pharma to promote digital technology reform in its new drug development and overall business productivity.
How did UiPath enhance value?
Since implementing UiPath in 2019, Mitsubishi Tanabe Pharma has automated more than 500 workflows, saving 70,000 hours and producing significant results in operational efficiency. The automation has enabled several tasks that human labor could not have realized, including contacting prospective employee retirees regarding offboarding procedures. The HR department previously received numerous monthly inquiries from retirees, which increased the workload. However, by entrusting software robots with the task of contacting retirees every month, the HR department has reduced workload and improved retiree satisfaction.
In the research and development field, Mitsubishi Tanabe Pharma has also developed workflows that add value to its business operations. For example, a workflow was created to crawl academic and social websites, sending an email to the individual in charge when there is updated information. Another workflow extracts necessary information from reports to support the creation of an application form that aggregates many accounts prepared by researchers and submits them to the proper medical authorities.
Mitsubishi Tanabe Pharma Provision Corporation has assumed the RPA Center of Excellence, consolidating all administrative tasks, including pharmaceutical information, accounting, general affairs, and HR for companies under the entire Group, into a single point contact. The introduction of the system proceeded on a “self-driven” basis, where on-site employees are encouraged to identify and automate target tasks independently.
How did UiPath Business Automation increase productivity?
The Center of Excellence has created a unique training program and has encouraged employees to participate actively. The goal is to develop a wide range of citizen developers, including those who can build workflows and determine which operations suit automation. They have also been developing and operating a new learning curriculum for training advanced developers in cooperation with UiPath.
Rob Enslin, Co-Chief Executive Officer of UiPath, said, “Today’s automation goes well beyond RPA – it’s the new way of operating and innovating. To this end, we are pleased to play a key role in Mitsubishi Tanabe Pharma Group’s automation journey by helping them achieve operational efficiency and improve their digital capabilities.”
As a next step, the company plans to develop its program and digital human resources further and create value-added operations to provide reskilling opportunities for senior personnel. By augmenting its automation program with citizen development, Mitsubishi Tanabe Pharma can future-proof its business and build a hybrid human-digital workforce of the future.
In conclusion, Mitsubishi Tanabe Pharma Corporation’s adoption of the UiPath Business Automation Platform has enabled the company to improve its operational efficiency and productivity, resulting in significant time savings and improved satisfaction among its retirees. The company’s unique training program has encouraged employees to identify and automate target tasks actively, resulting in a wide range of citizen developers. The company’s plan to further develop its program and digital human resources and create value-added operations to provide reskilling opportunities for senior personnel demonstrates its commitment to future-proofing its business and building a hybrid human-digital workforce.
